External-beam theranostic oncology company RefleXion Medical has officially announced the launch of the BIOGUIDE-X2 clinical study to expand indications for SCINTIX® biology-guided radiotherapy at Hackensack Meridian John Theurer Cancer Center. Additionally, the company shared updates from the Centers for Medicare and Medicaid (CMS) Services and starting this year CMS will provide broader reimbursement for SCINTIX therapy, including…